Home / General / FDA to Restrict GLP-1 Ingredients Used in Non‑approved Compounded Drugs

FDA to Restrict GLP-1 Ingredients Used in Non‑approved Compounded Drugs

US News is a recognized leader in college, grad school, hospital, mutual fund, and car rankings. Track elected officials, research health conditions, and find news you can use in politics, business, health, and education.

Feb 6 (Reuters) – The U.S. Food and ‌Drug ​Administration said on Friday ‌it plans to restrict GLP-1 ingredients used in ​non-approved compounded drugs that companies such as Hims & Hers and other compounding ‍pharmacies have been marketing ​as alter… [1507 chars]

Source: U.S. News & World Report | Published: 2026-02-06T21:59:00Z

Credit: U.S. News & World Report

Tagged:

Leave a Reply

Your email address will not be published. Required fields are marked *